Forzinity
From Discovery to FDA Approval: Forzinity Becomes First Therapy for Barth Syndrome
Forzinity (elamipretide) makes history as the first FDA-approved therapy for Barth syndrome. Learn about Hazel Szeto’s discovery, Stealth Biotherapeutics’ development journey, and the clinical evidence supporting approval.